Modification of the generalized Shwartzman reaction by therapeutic agents.
D000818:Animals; D004461:Eclampsia / Q000188:drug therapy*; D004731:Endotoxins; D005260:Female; D005337:Fibrin; D006584:Hexamethonium Compounds / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000187:drug effects; D008274:Magnesium / Q000627:therapeutic use*; D008297:Male; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011188:Potassium / Q000627:therapeutic use*; D011247:Pregnancy; D011817:Rabbits; D012790:Shwartzman Phenomenon / Q000188:drug therapy*; D014703:Veratrum / Q000627:therapeutic use*
D004731:Endotoxins; D006584:Hexamethonium Compounds; D005337:Fibrin; D008274:Magnesium; D011188:Potassium